01 Jun Optase Dry Eye Intense Drop (Glycerol 0.2%)
| Company name & Address: | registration number | Batch number(s) | Expiry date | Pack size | First release date | Re-call Classification | Recall date |
| Isoclear Pty Ltd Block C
The Village, Block A -1St Floor, c/o Oberon & Glenwood Roads Faerie Glen,0043 |
N/A |
3V35 3V36 5V45 9V12 |
31 August 2026 30 September 2026 31 March 2027 31 March 2027 |
1’s |
14 May 2025 14 May 2025 22 August 2025 20 August 2025 |
Class II Type B |
21 May 2026 |
Brief description of the problem (reason for recall)
This recall is initiated due to recommendation by FDA to Scope because of the citations issued during Manufacturer facility inspection in Jan 2026.
Advice for health professionals and distributors:
We request that you refrain from selling any of the affected batch(s) of Optase Dry Eye Intense Drops 10ml Multi use and return them to your supplying warehouse or distributor with immediate effect. Isoclear Pty Ltd will collect all your stock which will be replaced.
For further product information, please call Isoclear Pty Ltd on contact nr: 012-942-9382.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.